United States Healthcare Equipment & Supplies

Clearpoint Neuro Inc (CLPT)

Track

Over the past 90 days, Clearpoint Neuro Inc. has seen significant insider selling activity, totaling approximately $5.4 million in sales. Key transactions include multiple planned and proposed sales by CEO Joseph Burnett and several directors. These divestments follow the company's recent earnings report, which showed an EPS miss, despite a 43.3% increase in stock price over the period.
Ticker: CLPT Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Clearpoint Neuro Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 29 Jun 2026
Value US$3,479,922.37 | Price 121.92 | Shares 97,955 (-29.4%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-01 2026-06-29 PlS Planned sale
2.2
BURNETT JOSEPH

CEO and President

Executive Director
97,955 -29.4%
121.92
US$3,479,922 		97,955 -29.4% 121.92 US$3,479,922
2026-06-29 2026-06-29 PrS Proposed sale
2.2
JOSEPH BURNETT

Director; Officer

Executive Director
54,054
256.39
US$3,899,275 		54,054 256.39 US$3,899,275
2026-06-22 2026-06-17 PlS Planned sale
2.2
BURNETT JOSEPH

CEO and President

Executive Director
42,722 +48.5%
219.70
US$2,826,924 		42,722 +48.5% 219.70 US$2,826,924
2026-06-22 2026-06-17 PlS Planned sale
2.2
BURNETT JOSEPH

CEO and President

Executive Director
1,843 -1.0%
17.94
US$33,063 		1,843 -1.0% 17.94 US$33,063
2026-06-22 2026-06-17 PlS Planned sale
2.2
BURNETT JOSEPH

CEO and President

Executive Director
60,000 -33.9%
17.79
US$1,067,400 		60,000 -33.9% 17.79 US$1,067,400
2026-06-22 2026-06-17 PlS Planned sale
2.2
BURNETT JOSEPH

CEO and President

Executive Director
60,000 -33.9%
17.79
US$1,067,400 		60,000 -33.9% 17.79 US$1,067,400
2026-06-17 2026-06-17 PrS Proposed sale
2.2
JOSEPH M BURNETT TRUST

Affiliate of Director

Non-Executive Director
1,843
13.34
US$24,586 		1,843 13.34 US$24,586
2026-06-17 2026-06-17 PrS Proposed sale
2.2
JOSEPH BURNETT

Director; Officer

Executive Director
60,000
13.34
US$800,400 		60,000 13.34 US$800,400
2026-06-02 2026-06-01 S Sale
1.8
Richards Timothy T.
Non-Executive Director
5,415 -5.8%
12.17
US$65,901 		5,415 -5.8% 12.17 US$65,901
2026-06-01 2026-06-01 PrS Proposed sale
1.8
TIMOTHY RICHARDS

Director

Non-Executive Director
5,145
12.17
US$62,612 		5,145 12.17 US$62,612
2026-05-29 2026-05-29 PrS Proposed sale
PASCAL E. GIRIN

Director

Non-Executive Director
66,679
12.54
US$836,455 		66,679 12.54 US$836,455
2026-05-26 2026-05-21 S Sale
3.0
Klein Matthew B.
Non-Executive Director
16,000 -25.4%
11.59
US$185,440 		16,000 -25.4% 11.59 US$185,440
2026-05-21 2026-05-21 PrS Proposed sale
3.0
MATTHEW B KLEIN

Director

Non-Executive Director
16,000
11.59
US$185,392 		16,000 11.59 US$185,392
2026-05-21 2026-05-21 PrS Proposed sale
3.0
MATTHEW B KLEIN

Director

Non-Executive Director
16,000
11.59
US$185,392 		16,000 11.59 US$185,392
2026-05-21 2026-05-20 PlS Planned sale
3.1
FALLON LYNNETTE C
Non-Executive Director
5,091 -9.5%
11.14
US$56,714 		5,091 -9.5% 11.14 US$56,714
2026-05-20 2026-05-20 PrS Proposed sale
3.1
LYNNETTE C FALLON

Director

Non-Executive Director
5,091
11.17
US$56,866 		5,091 11.17 US$56,866
2026-02-26 2026-02-25 PlS Planned sale
2.2
BURNETT JOSEPH

CEO and President

Executive Director
19,951 -9.4%
15.17
US$302,657 		19,951 -9.4% 15.17 US$302,657
2026-02-25 2026-02-25 PrS Proposed sale
2.2
JOSEPH M BURNETT TRUST

Affiliate of Director

Non-Executive Director
21,794
14.55
US$317,103 		21,794 14.55 US$317,103
2026-01-27 2026-01-26 PlS Planned sale
2.2
BURNETT JOSEPH

CEO and President

Executive Director
2,943 -1.4%
15.57
US$45,823 		2,943 -1.4% 15.57 US$45,823
2026-01-26 2026-01-26 PrS Proposed sale
2.2
JOSEPH M BURNETT TRUST

Affiliate of Director

Non-Executive Director
2,943
15.68
US$46,146 		2,943 15.68 US$46,146
2026-02-20 2026-01-09 PrS Proposed sale
2.2
BURNETT JOSEPH

Officer; Director

Executive Director
20,000
15.31
US$306,200 		20,000 15.31 US$306,200
2026-01-13 2026-01-09 PlS Planned sale
2.2
BURNETT JOSEPH

CEO and President

Executive Director
20,000 -63.4%
16.12
US$322,400 		20,000 -63.4% 16.12 US$322,400
2026-01-09 2026-01-09 PrS Proposed sale
2.2
JOSEPH M BURNETT

Director; Officer

Executive Director
20,000
15.31
US$306,200 		20,000 15.31 US$306,200
2025-11-12 2025-11-12 PrS Proposed sale
PTC Therapeutics, Inc.

Affiliate of director

Non-Executive Director
894,578
16.53
US$14,787,374 		894,578 16.53 US$14,787,374
2025-10-14 2025-10-10 PlS Planned sale
2.2
BURNETT JOSEPH

CEO and President

Executive Director
300 -0.1%
29.21
US$8,763 		300 -0.1% 29.21 US$8,763
2025-10-14 2025-10-10 PlS Planned sale
2.2
BURNETT JOSEPH

CEO and President

Executive Director
1,981 -0.9%
28.64
US$56,736 		1,981 -0.9% 28.64 US$56,736
2025-10-14 2025-10-10 PlS Planned sale
2.2
BURNETT JOSEPH

CEO and President

Executive Director
6,599 -2.9%
27.64
US$182,396 		6,599 -2.9% 27.64 US$182,396
2025-10-14 2025-10-10 PlS Planned sale
2.2
BURNETT JOSEPH

CEO and President

Executive Director
17,583 -7.2%
26.51
US$466,125 		17,583 -7.2% 26.51 US$466,125
2025-10-10 2025-10-10 PrS Proposed sale
2.2
JOSEPH M BURNETT TRUST

Affiliate of Director

Non-Executive Director
26,463
28.96
US$766,368 		26,463 28.96 US$766,368
2025-06-12 2025-06-10 S Sale
1.8
Richards Timothy T.
Non-Executive Director
10,000 -11.4%
13.28
US$132,800 		10,000 -11.4% 13.28 US$132,800
2025-06-10 2025-06-10 PrS Proposed sale
1.8
TIMOTHY RICHARDS

Director

Non-Executive Director
10,000
13.28
US$132,843 		10,000 13.28 US$132,843
2025-06-11 2025-06-09 S Sale
2.2
BURNETT JOSEPH

CEO and President

Executive Director
21,247 -8.0%
13.29
US$282,373 		21,247 -8.0% 13.29 US$282,373
2025-06-09 2025-06-09 PrS Proposed sale
2.2
JOSEPH M BURNETT TRUST

Officer; Director

Executive Director
21,247
13.29
US$282,358 		21,247 13.29 US$282,358
2025-06-05 2025-06-03 S Sale
3.1
FALLON LYNNETTE C
Non-Executive Director
1,200 -2.9%
12.88
US$15,456 		1,200 -2.9% 12.88 US$15,456
2025-06-05 2025-06-03 S Sale
3.1
FALLON LYNNETTE C
Non-Executive Director
9,000 -17.6%
12.53
US$112,770 		9,000 -17.6% 12.53 US$112,770
2025-06-03 2025-06-03 PrS Proposed sale
3.1
LYNNETTE FALLON

Director

Non-Executive Director
10,200
12.57
US$128,231 		10,200 12.57 US$128,231
2023-06-05 2023-06-05 PrS Proposed sale
PTC Therapeutics, Inc.

10% Stockholder

Large shareholder
400,000
7.76
US$3,104,000 		400,000 7.76 US$3,104,000
2022-08-16 2022-08-15 PlS Planned sale
2.2
BURNETT JOSEPH MICHAEL

CEO and President

Executive Director
18,867 -6.7%
16.07
US$303,193 		18,867 -6.7% 16.07 US$303,193
2021-11-12 2021-11-11 PlS Planned sale
2.2
BURNETT JOSEPH MICHAEL

CEO and President

Executive Director
10,000 -4.3%
16.88
US$168,800 		10,000 -4.3% 16.88 US$168,800
2021-06-22 2021-06-21 PlS Planned sale
2.2
BURNETT JOSEPH MICHAEL

CEO and President

Executive Director
25,000 -9.5%
18.57
US$464,250 		25,000 -9.5% 18.57 US$464,250
2018-09-25 2018-09-25 B Purchase BURNETT JOSEPH MICHAEL

President and CEO

Executive Director
25,000 +10.8%
1.25
US$31,250 		25,000 +10.8% 1.25 US$31,250
2018-08-24 2018-08-24 B Purchase BURNETT JOSEPH MICHAEL

President and CEO

Executive Director
7,500 +3.2%
1.58
US$11,850 		7,500 +3.2% 1.58 US$11,850
2018-08-24 2018-08-22 B Purchase BURNETT JOSEPH MICHAEL

President and CEO

Executive Director
4,637 +2.0%
1.55
US$7,187 		4,637 +2.0% 1.55 US$7,187
2018-05-23 2018-05-21 B Purchase BURNETT JOSEPH MICHAEL

President and CEO

Executive Director
7,500 +1.4%
2.39
US$17,902 		7,500 +1.4% 2.39 US$17,902
2017-05-30 2017-05-26 B Purchase Jenkins Kimble L. Non-Executive Director
7,500
0.00
US$0 		7,500 0.00 US$0
2017-05-30 2017-05-26 B Purchase Grillo Francis P

CHIEF EXECUTIVE OFFICER

Executive Director
12,500
0.00
US$0 		12,500 0.00 US$0
2016-09-07 2016-09-02 B Purchase Rooke Andrew K. Non-Executive Director
10,000
0.00
US$0 		10,000 0.00 US$0
2016-09-07 2016-09-02 B Purchase Grillo Francis P

CHIEF EXECUTIVE OFFICER

Executive Director
20,000
0.00
US$0 		20,000 0.00 US$0
2014-09-15 2014-09-12 B Purchase SPENCER JOHN N JR Non-Executive Director
6,000 +400.0%
1.18
US$7,080 		6,000 +400.0% 1.18 US$7,080
2014-09-15 2014-09-12 B Purchase SPENCER JOHN N JR Non-Executive Director
10,000 +11.5%
1.18
US$11,800 		10,000 +11.5% 1.18 US$11,800
2014-08-14 2014-08-13 B Purchase SPENCER JOHN N JR Non-Executive Director
3,500 +4.2%
1.00
US$3,500 		3,500 +4.2% 1.00 US$3,500
2014-06-16 2014-06-13 B Purchase Rooke Andrew K. Non-Executive Director Large shareholder
30,000 +9.7%
0.73
US$21,900 		30,000 +9.7% 0.73 US$21,900
2014-06-12 2014-06-10 B Purchase Rooke Andrew K. Non-Executive Director Large shareholder
50,000 +19.2%
0.78
US$39,210 		50,000 +19.2% 0.78 US$39,210
2013-08-20 2013-08-19 B Purchase PIETRANGELO MICHAEL Non-Executive Director
100,000 +28.5%
1.27
US$127,000 		100,000 +28.5% 1.27 US$127,000
2013-06-12 2013-06-11 B Purchase PIETRANGELO MICHAEL Non-Executive Director
41,855 +14.1%
1.10
US$46,040 		41,855 +14.1% 1.10 US$46,040
2013-05-14 2013-05-13 B Purchase SPENCER JOHN N JR Non-Executive Director
1,500 +inf%
1.32
US$1,980 		1,500 +inf% 1.32 US$1,980
2013-03-25 2013-03-22 B Purchase Conway Bruce C. Non-Executive Director
2,500 +16.7%
1.48
US$3,700 		2,500 +16.7% 1.48 US$3,700
2013-03-21 2013-03-20 B Purchase Conway Bruce C. Non-Executive Director
2,300 +0.9%
1.50
US$3,450 		2,300 +0.9% 1.50 US$3,450
2013-03-21 2013-03-19 B Purchase Conway Bruce C. Non-Executive Director
200 +0.1%
1.49
US$298 		200 +0.1% 1.49 US$298
2013-03-18 2013-03-14 B Purchase Conway Bruce C. Non-Executive Director
5,000 +30.3%
1.50
US$7,500 		5,000 +30.3% 1.50 US$7,500
2013-03-18 2013-03-14 B Purchase Conway Bruce C. Non-Executive Director
5,000 +30.3%
1.50
US$7,500 		5,000 +30.3% 1.50 US$7,500
2013-03-18 2013-03-14 B Purchase Conway Bruce C. Non-Executive Director
5,000 +30.3%
1.50
US$7,500 		5,000 +30.3% 1.50 US$7,500
2013-03-18 2013-03-14 B Purchase Conway Bruce C. Non-Executive Director
5,000 +50.0%
1.50
US$7,500 		5,000 +50.0% 1.50 US$7,500
2013-03-18 2013-03-14 B Purchase Conway Bruce C. Non-Executive Director
3,665 +10.5%
1.46
US$5,351 		3,665 +10.5% 1.46 US$5,351
2013-03-18 2013-03-14 B Purchase Conway Bruce C. Non-Executive Director
7,500 +3.1%
1.50
US$11,250 		7,500 +3.1% 1.50 US$11,250
2013-03-18 2013-03-14 B Purchase Conway Bruce C. Non-Executive Director
1,500 +0.1%
1.49
US$2,235 		1,500 +0.1% 1.49 US$2,235
2013-03-14 2013-03-13 B Purchase Conway Bruce C. Non-Executive Director
2,000 +0.1%
1.50
US$3,000 		2,000 +0.1% 1.50 US$3,000
2013-03-12 2013-03-11 B Purchase Conway Bruce C. Non-Executive Director
10,000 +inf%
1.50
US$15,000 		10,000 +inf% 1.50 US$15,000
2013-03-12 2013-03-11 B Purchase Conway Bruce C. Non-Executive Director
10,000 +40.0%
1.56
US$15,550 		10,000 +40.0% 1.56 US$15,550
2013-03-12 2013-03-11 B Purchase Conway Bruce C. Non-Executive Director
3,500 +1.5%
1.58
US$5,526 		3,500 +1.5% 1.58 US$5,526
2013-03-12 2013-03-11 B Purchase Conway Bruce C. Non-Executive Director
5,050 +0.2%
1.55
US$7,828 		5,050 +0.2% 1.55 US$7,828
2012-09-18 2012-09-14 B Purchase Conway Bruce C. Non-Executive Director
1,000 +6.2%
2.25
US$2,250 		1,000 +6.2% 2.25 US$2,250
2012-09-18 2012-09-14 B Purchase Conway Bruce C. Non-Executive Director
1,000 +6.2%
2.27
US$2,270 		1,000 +6.2% 2.27 US$2,270
2012-09-18 2012-09-14 B Purchase Conway Bruce C. Non-Executive Director
1,000 +6.2%
2.25
US$2,250 		1,000 +6.2% 2.25 US$2,250
2012-09-18 2012-09-14 B Purchase Conway Bruce C. Non-Executive Director
1,000 +6.5%
2.00
US$2,000 		1,000 +6.5% 2.00 US$2,000
Explore more

More insider trading research around Clearpoint Neuro Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America